SCHEMBL7983312

SCHEMBL7983312

CC[C@@H](O)CC(Oc1ccc(-c2ccccc2)cc1)c1cccnc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP19A1 P11511 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KCNA5 P22460 2/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
CYP17A1 P05093 1/20 0.40
ADRB1 P08588 3/20 0.39
ADRB3 P13945 3/20 0.39
MAPT P10636 1/20 0.39
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KCNH2 Q12809 1/20 0.39
SLC6A9 P48067 2/20 0.38
CYP51A1 Q16850 1/20 0.38
PSMB5 P28074 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8553465 1.00 SMN1; SMN2 (0.42) SMN1; SMN2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL8554094 0.99 SMN1; SMN2 (0.41) SMN1; SMN2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL8109544 0.88 SMN1; SMN2 (0.44) SMN1; SMN2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL8552624 0.82 CYP19A1 (0.47) SMN1; SMN2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL8118264 0.78 DGAT2 (0.39) CYP3A4CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL8133883 0.78 CYP17A1 (0.40) SMN1; SMN2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL8550969 0.77 EPHX1 (0.46) SMN1; SMN2KCNA5ADRB1ADRB3KCNH2
SCHEMBL8552459 0.77 CYP17A1 (0.44) CYP3A4CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL8555652 0.77 PPARG (0.41) SMN1; SMN2CYP3A4CYP2C9KCNA5CYP17A1
SCHEMBL8118468 0.76 KCNA5 (0.45) CYP3A4CYP19A1KCNA5SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300352-B1 FOR THERAPY OF ASTHMA ASTRAZENECA AB (SE) 2001-10-09 US claimed